Tesamorelin Co
Tesamorelin: the FDA-approved GHRH analogue, its trial evidence, dosing and visceral fat indication
63 in-depth articlesEvidence-basedPubMed & FDA sources
Browse by topic
All articles
DosingBest time to take tesamorelin peptide: what the trials showPhase 3 trials dosed tesamorelin nightly before bed. Here's why timing matters, what the evidence actually covers, and what's off-label guesswork.SourcingDoes tesamorelin need to be refrigerated? Storage rules explainedYes. Reconstituted tesamorelin (Egrifta) must stay refrigerated at 2-8°C and gets used within 14 to 30 days. Here's what the label and studies actually say.EvidenceHow long does tesamorelin take to work?Phase 3 data show visceral fat drops start by week 14; full 26-week trials show ~15-18% VAT reduction. Here's the real timeline, by outcome.DosingHow to reconstitute tesamorelin: a step by step guidetesamorelin (egrifta) ships as a lyophilized powder that must be mixed with sterile water before injection. here's the exact process, step by step.SourcingIs tesamorelin FDA approved? Yes, for one specific useTesamorelin (Egrifta) is FDA approved, but only to reduce excess visceral fat in HIV lipodystrophy. Here's what the approval covers and what it doesn't.SafetyIs tesamorelin safe? what the FDA trials actually showTesamorelin is FDA-approved with phase 3 safety data in HIV lipodystrophy. Here's what the trials found on side effects, glucose, and who should avoid it.SafetyTesamorelin and athletes: drug testing status explainedTesamorelin is a GHRH analogue banned in competitive sport under WADA's S2 category. Here's the detection science, testing reality, and what athletes should know.SafetyTesamorelin and blood work: what to test and whenTesamorelin needs baseline and follow-up labs: IGF-1, glucose, A1c, liver enzymes. Here's what the phase 3 trials actually monitored and why it matters.EvidenceTesamorelin: animal studies vs human clinical evidenceTesamorelin's approval rests on two phase 3 human trials, not animal data. See what's proven, what's extrapolated, and what's still off-label.EvidenceTesamorelin before and after claims: what the trials actually showTesamorelin trials show an 18% average visceral fat drop at 26 weeks in HIV lipodystrophy. Here's what before/after photos leave out, sourced to phase 3 data.SourcingTesamorelin certificate of analysis explainedWhat a tesamorelin COA should show, why FDA-approved Egrifta doesn't need one for patients, and how to read purity, sterility, and identity data.SafetyTesamorelin contraindications: who should not use itEgrifta's label warns against use in active cancer, pituitary/pregnancy, and hypersensitivity to tesamorelin or mannitol. Full contraindication breakdown here.SourcingTesamorelin cost: what egrifta and generic vials actually runEgrifta list price tops $5,000/month before coupons. Compounded tesamorelin runs far less. Here's what actually drives tesamorelin cost and what to check first.SourcingTesamorelin cost and pricing: what it actually costs in 2026Brand Egrifta runs well over $1,000/month before insurance; compounded tesamorelin costs far less but carries different risk. Here's the real pricing breakdown.DosingTesamorelin cycle length: how long should a course run?The phase 3 trials ran tesamorelin for 26 to 52 weeks continuously, not in on/off cycles. Here's what the trial data actually supports.DosingTesamorelin half life: how long it stays active in the bodyTesamorelin's plasma half life is roughly 25 to 38 minutes. Here's what that means for dosing schedule, timing, injection frequency, and clearance.DosingTesamorelin how to inject: a step-by-step protocol guideHow to reconstitute and inject tesamorelin correctly, based on the phase 3 trial protocol (2 mg SC daily) behind FDA-approved Egrifta. Step-by-step, sourced.EvidenceTesamorelin human studies: what the trials actually showTesamorelin's phase 3 trials cut visceral fat about 18% in HIV lipodystrophy. Here's what the human evidence covers, and where it stops.DosingTesamorelin injection sites: where and how to injectTesamorelin (Egrifta) is injected subcutaneously into the abdomen, with sites rotated daily. Here's the FDA label guidance and what the phase 3 trials actually used.SourcingTesamorelin legal status: FDA-approved use vs off-label realityTesamorelin (Egrifta) is FDA-approved only for HIV lipodystrophy. Here's what that actually means for prescriptions, compounding, and off-label use.EvidenceTesamorelin mechanism of action: how it works in the bodyTesamorelin is a GHRH analogue that stimulates the pituitary to release GH in pulses. Here's the receptor biology behind its FDA-approved fat-reduction effect.SourcingTesamorelin prescription requirements: what you actually needTesamorelin (Egrifta) is prescription-only in the US, FDA-approved only for HIV lipodystrophy. Here's what a legal prescription requires, and where off-label use stands.SafetyTesamorelin side effects: what the phase 3 trials actually foundFDA trials found injection site reactions in about 25% of patients and joint pain in about 13%. Here's the full side effect profile of tesamorelin, cited.DosingTesamorelin storage and shelf life, refrigeration rulesHow to store tesamorelin before and after reconstitution: fridge temps, freezer stability, powder shelf life, and when a reconstituted vial actually goes bad.ComparisonsTesamorelin vs Egrifta: what's actually the difference?Egrifta is the FDA-approved brand of tesamorelin. There's no pharmacological difference, just legal status, source, and price. Here's the full comparison.ComparisonsTesamorelin vs ipamorelin: what the evidence actually showsTesamorelin is FDA-approved with phase 3 data for HIV lipodystrophy; ipamorelin has no FDA approval and no comparable human trials. Here's the real gap.SourcingBest peptide to stack with tesamorelin: a reality checkNo approved trial ever tested tesamorelin stacked with another peptide. Here's what the phase 3 data actually covers, and what stacking really means for risk.SourcingBest place to buy tesamorelin: a buyer's reality checkEgrifta is FDA-approved by prescription only; compounded tesamorelin fills the off-label gap. Here's what actually determines a safe, legitimate source.SourcingBest place to buy tesamorelin online: a buyer's reality checkEgrifta is FDA-approved but narrow-indication. Here's what real sourcing looks like, what a prescription requires, and how to avoid a bad batch.EvidenceBest tesamorelin peptide: how to actually evaluate oneThere's no "best" tesamorelin brand, only FDA-approved Egrifta and compounded copies. Here's the real evidence, dosing and sourcing checklist before you buy.EvidenceCan women take tesamorelin peptide? what the evidence saysTesamorelin (Egrifta) is FDA-approved for HIV lipodystrophy in adults, not sex-restricted. Here's what the trial data on women actually shows, and what's off-label.EvidenceDoes tesamorelin cause cancer? what the trial data showsTesamorelin's phase 3 trials found no increased cancer signal, but the label carries an IGF-1 caution and cancer patients were excluded. Here's the actual evidence.ComparisonsHexarelin vs tesamorelin: what the evidence actually showsTesamorelin is FDA-approved with phase 3 trial data for HIV lipodystrophy. Hexarelin isn't approved for anything. Here's the real evidence gap.EvidenceHow long does it take for tesamorelin to work?Trial data shows visceral fat drops start by week 14, with full effect around 26 weeks. Here's the real timeline from the phase 3 tesamorelin studies.EvidenceHow to get tesamorelin: the legal, provider-reviewed routeTesamorelin (Egrifta) is FDA-approved by prescription only, for HIV lipodystrophy. Here's the real path to get it, on-label or off-label, and what to skip.SourcingHow to get tesamorelin peptide: the legal, evidence-based routesTesamorelin (Egrifta) is FDA-approved by prescription only for HIV lipodystrophy. Here's how prescriptions, compounding pharmacies, and telehealth actually work.DosingHow to take tesamorelin peptide: the actual injection stepsTesamorelin is injected subcutaneously once daily, 2mg reconstituted, on an empty stomach at night. Here is the real phase 3 protocol and how to follow it.SourcingHow to verify tesamorelin quality before you inject itEgrifta is FDA-approved with phase 3 data; compounded tesamorelin is not. Here's exactly how to check purity, sourcing, and paperwork before you buy.ComparisonsIGF-1 LR3 vs tesamorelin: what the evidence actually saysTesamorelin is FDA-approved with phase 3 data for HIV lipodystrophy. IGF-1 LR3 has no such trials and no legal path to compounding. Here's the real comparison.EvidenceTesamorelin: the FDA-approved GHRH analogue, explainedTesamorelin (Egrifta) is FDA-approved for HIV lipodystrophy visceral fat. Phase 3 data, dosing, off-label use, and safety facts, sourced and explained.EvidenceTesamorelin clinical trials: what the phase 3 data actually showsTesamorelin (Egrifta) cut visceral fat about 15-18% in phase 3 HIV trials vs placebo. Here's the trial evidence, what it covers, and what it doesn't.SourcingTesamorelin compounding pharmacy vs research supplierTesamorelin is FDA-approved only as branded Egrifta. Compare compounded 503A/503B pharmacy sourcing against research-chemical sellers before you buy.DosingTesamorelin dosage: the approved 2mg protocol, explainedThe FDA-approved tesamorelin dose is 2mg/day subcutaneous. Here's the trial evidence, mixing math for 2mg and 5mg vials, and why more isn't better.DosingTesamorelin dosage calculator: how to work out your doseThe approved tesamorelin dose is 2 mg/day by injection. Here's how a reconstitution calculator works, why it can't replace a prescriber, and what the trials actually tested.SafetyTesamorelin drug interactions: what actually mattersTesamorelin has no major CYP-based drug interactions, but it can raise blood sugar and change how other drugs are dosed. Here's the real interaction list.EvidenceTesamorelin in women: what the evidence actually showsEgrifta's phase 3 trials for HIV lipodystrophy enrolled few women. Here's the real female-specific evidence, dosing, and off-label questions answered.SafetyTesamorelin long term side effects: what the trials showEgrifta's phase 3 safety extension ran 52 weeks. Here's what long term tesamorelin side effects look like in the actual trial data, and what's still unknown.EvidenceTesamorelin nasal spray: is there a clinical trial?No approved tesamorelin nasal spray exists. FDA approval covers Egrifta injection only, backed by two phase 3 trials. Here's what the evidence actually shows.EvidenceTesamorelin before and after: what the trial data actually showPhase 3 trials found ~18% visceral fat reduction at 26 weeks with tesamorelin. Here's the real timeline, what changes, and what doesn't.SourcingTesamorelin peptide near me: what to actually look forSearching "tesamorelin peptide near me"? Here's what FDA approval covers, why sourcing matters more than location, and how to find a legitimate provider.SafetyTesamorelin peptide side effects: what the trials actually showInjection site reactions hit roughly 25-35% of tesamorelin users in trials. Here's the full side effect profile from the phase 3 data, plain and unranked.EvidenceTesamorelin peptide stacks: what the evidence actually supportsTesamorelin is FDA-approved alone, for one indication. Stacking with IGF-1 LR3 or other peptides has no phase 3 data. Here's what's actually known.SourcingTesamorelin purity and testing: what buyers need to checkEgrifta is FDA-approved, but compounded tesamorelin isn't. Here's what purity testing means, why it matters, and how to check a source before you buy.DosingTesamorelin reconstitution: how to mix it correctlyStep-by-step tesamorelin reconstitution: bacteriostatic water amount, mixing technique, storage life after reconstitution, and what the labeling actually says.EvidenceTesamorelin results: what the clinical research actually showsTesamorelin cut visceral fat about 18% in phase 3 trials for HIV lipodystrophy. Here's the real evidence, what it doesn't show, and what's still off-label.ComparisonsTesamorelin stacks: what the evidence actually supportsTesamorelin has phase 3 data alone, not in combination. Here's what's known, what's guessed, and what stacking with other peptides actually risks.EvidenceTesamorelin timeline: what to expect week by weekPhase 3 data show visceral fat drops start by week 14 and hold through 26-52 weeks. Here's the realistic tesamorelin timeline, dosed on real trial evidence.ComparisonsTesamorelin vs CJC-1295: what the evidence actually saysTesamorelin is FDA-approved for HIV lipodystrophy with phase 3 data. CJC-1295 has no FDA approval and no human trials. Here's the real comparison.ComparisonsTesamorelin vs growth hormone: what the evidence showsTesamorelin is an FDA-approved GHRH analogue for HIV lipodystrophy; HGH is a hormone with broader, riskier off-label use. Compare data, dosing, and safety.ComparisonsTesamorelin vs HGH: comparing the evidence, dosing, and riskTesamorelin is FDA-approved for one indication with phase 3 trial data; HGH for anti-aging is off-label and unapproved. Compare evidence, dosing, and safety.ComparisonsTesamorelin vs sermorelin: what the evidence actually showsTesamorelin has FDA approval and phase 3 trial data for visceral fat in HIV lipodystrophy. Sermorelin does not. Here's the head-to-head comparison.EvidenceWhat does tesamorelin actually do in the body?Tesamorelin is FDA-approved for HIV lipodystrophy: phase 3 trials show real visceral fat drops. Here's what it does, and doesn't do, backed by the data.EvidenceWhen to take tesamorelin: timing, cycle length, and dosingTesamorelin is dosed once daily at bedtime by subcutaneous injection. Here's what the phase 3 trials actually say about timing, cycles, and food.